L’Oreal Says Makeup Will Be Back, But ‘Health Is The Future Of Beauty’
Executive Summary
Dermocosmetics was L’Oreal’s biggest growth story in 2020, benefiting from shifting consumer priorities during the COVID crisis and reinvigorated faith in the recommendations of healthcare professionals. Makeup sales tanked, but that could well reverse with the advent of another Roaring Twenties post-pandemic, L’Oreal leadership suggests.
You may also be interested in...
L’Oréal Partners With Microalgae Biotech For New Cosmetic Actives
French firms L’Oréal and Microphyt partner to drive development of cosmetic solutions based on the latter’s patented, low-carbon process for cultivating microalgae. Already, Microphyt markets three cosmetic ingredients based on microalgae bioactives for enhanced skin vitality and resilience.
Dermocosmetics Opportunity Beckons: Top 20 Brands Account For Just 35% Of Global Market – IQVIA
The global dermocosmetics market is led by L’Oréal SA with 13.3% share across 20 countries evaluated, followed by Pierre Fabre Group with 7.4%. According to IQVIA Consumer Health, this points to a fragmented market with ample room for innovative, “nimble” brands to enter and nab share.
Five Years Post-Coty Deal, P&G Beauty Is Riding Out Pandemic In Style
Procter & Gamble Co.’s Beauty division has weathered COVID challenges exceptionally well thanks to its portfolio mix and the health of its brands going into the pandemic, Beauty CEO R. Alexandra Keith said at the Barclay Global Consumer Staples Conference on 9 September.